Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and pharmacokinetics of estetrol + drospirenone oral contraceptive in post-menarchal adolescents
2019-003002-27Phase 3Completed
- Sponsor
- Estetra SRL
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of estetrol + drospirenone in menstrual disorders, sponsored by Estetra SRL. Primary endpoint: Treatment-emergent adverse events. Started Apr 2020; status: completed.
02
Drugs
estetrol + drospirenone
03
Conditions
menstrual disorders
Beyond the preview
Go deeper on 2019-003002-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003002-27.